Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 14 Breast Neoplasms 14 Lung Neoplasms 12 Head and Neck Neoplasms 10 Rectal Neoplasms 8 Prostatic Neoplasms 7 Mouth Neoplasms 5 Glioblastoma 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Hypopharyngeal Neoplasms 4 Gliosarcoma 4 Carcinoma 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Ovarian Neoplasms 3 Neuroblastoma 3 Neoplasms 3 Laryngeal Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Dysplasia 2 Turcot syndrome 2 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 toripalimab 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 seviteronel 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Celecoxib × Clear all

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡